X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

FIXX

Closed

Homology Medicines Inc

0.892
-0.043 (-4.60%)
Last Update: 26 Mar 2024 01:27:00
Yesterday: 0.9347
Day's Range: 0. - 0.
Send
When Written:
 
0.9901
Homology Medicines Inc is a clinical-stage genetic medicines company that develops gene therapies for patients with rare genetic diseases. The company's proprietary platform is based on the use of adeno-associated virus (AAV) vectors, which are engineered to deliver genetic material to specific cells in the body. Homology Medicines' lead product candidate is HMI-102, a gene therapy for the treatment of phenylketonuria (PKU), a rare metabolic disorder. The company is also developing gene therapies for other rare genetic diseases, including metachromatic leukodystrophy (MLD) and mucopolysaccharidosis type I (MPS I). Homology Medicines was founded in 2015 and is headquartered in Bedford, Massachusetts.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X